Agonist News and Research

RSS

Pharmacy-level barriers limit treatment for opioid use disorder in Appalachian Kentucky

A new study led by University of Kentucky researcher April Young and Emory University researcher Hannah Cooper shows that a number of pharmacies in the Appalachian region of Kentucky are limiting the dispensing of buprenorphine, a medication used to treat opioid use disorder.

28 Apr 2020

New potential treatment candidate identified for early type 2 diabetic retinopathy

Diabetic retinopathy is one of the main vascular complications of type 2 diabetes, and the most common cause of visual deterioration in adults.

27 Apr 2020

Study shows variability in Medicare coverage for transgender hormone therapies

A new study has shown substantial variability in access to guideline-recommended hormone therapies for older transgender individuals insured through Medicare.

13 Apr 2020

Newer therapies may benefit patients with type 2 diabetes and coronary artery disease

Type 2 diabetes affects treatment options for patients who have both coronary artery disease and T2D, according to a new American Heart Association Scientific Statement, published today in the Association's flagship journal Circulation.

13 Apr 2020

People with type 2 diabetes and heart disease may benefit from newer therapies

Type 2 diabetes (T2D) may affect treatment options for patients who have both coronary artery disease (CAD) and T2D.

13 Apr 2020

Two newer types of diabetes medications show heart and kidney benefits

Two newer types of medications commonly used to treat type 2 diabetes are similar in their ability to reduce major heart complications, including heart attack, stroke and death from cardiovascular disease, according to research accepted for presentation at ENDO 2020, the Endocrine Society's annual meeting, and publication in a special supplemental section of the Journal of the Endocrine Society.

31 Mar 2020

Study sheds light on myelin's role in 'chemobrain' and multiple sclerosis

Scientists have discovered that myelin is not as metabolically inert as has previously been thought.

23 Mar 2020

Three-drug combination reduces all-cause mortality in COPD patients

Once-daily treatment of patients with chronic obstructive pulmonary disease (COPD) with an inhaler combining fluticasone furoate (FF), umeclidinium (UMEC) and vilanterol (VI) reduced all-cause mortality by 42 percent, according to new research published online in the American Thoracic Society's American Journal of Respiratory and Critical Care Medicine.

18 Mar 2020

Comprehensive new clinical guideline on homelessness released

A collaborative approach is required to build healthcare pathways that will end homelessness in Canada, says the Homeless Health Research Network, a pan-Canadian team of experts including researchers from McGill University.

9 Mar 2020

Collaborative approach needed to build pathways to end homelessness in Canada

A collaborative approach is required to build health care pathways that will end homelessness in Canada. Clinicians can play a role by tailoring their interventions using a comprehensive new clinical guideline on homelessness published in CMAJ (Canadian Medical Association Journal).

9 Mar 2020

Researchers identify mechanism that explains why women experience more pain than men

Imagine taking a pill to control your pain and, instead, the medication actually increases the pain you feel.

5 Mar 2020

Nearly $4 million to fund drug discovery research for Alzheimer's, other dementia

The Alzheimer's Association and the Rainwater Charitable Foundation have joined forces again to fund drug discovery research towards finding therapies for Alzheimer's disease, frontotemporal degeneration, and other tauopathies.

4 Mar 2020

Medication treatments for OUD led to 80% lower risk of death from opioid overdose

Patients with opioid use disorder receiving treatment with opioid agonists (medications such as methadone or buprenorphine) had an 80 percent lower risk of dying from an opioid overdose compared to patients in treatment without the use of medications.

25 Feb 2020

Researchers find the potential of opioid drug to help mask fear memory

Anxiety disorders such as phobias and PTSD are fairly common problems in society. One of the prime causes of anxiety disorders is the inability to overcome the fear for certain contexts when they no longer apply.

19 Feb 2020

Novel drug combination discovered to induce high rates of human beta cell proliferation

Researchers at the Icahn School of Medicine at Mount Sinai have discovered a novel combination of two classes of drugs that, together, cause the highest rate of proliferation ever observed in adult human beta cells- the cells in the pancreas that produce insulin- without harming most other cells in the body.

12 Feb 2020

60+ organizations to speak as the NASH Summit Boston returns

Hansonwade will present the 4th NASH Summit in Boston from May 4-7, 2020. For its anticipated return, the forum is set to widen its program and congregate over 350+ industry stakeholders for presentations from global regulatory agencies and leading biopharma.

From 4th NASH Summit Boston 29 Jan 2020

Majority of people knowingly use fentanyl, UBC research shows

Fentanyl use by people who use drugs has doubled since 2015, and two-thirds of people are aware they've taken it, finds new research out of British Columbia, the Canadian province that has experienced the highest number of illicit drug toxicity deaths as a result of the opioid crisis.

24 Jan 2020

Integral Molecular announces panel of P2X7 antibodies for autoimmune disorders

Integral Molecular, the leader in discovering antibodies against multipass membrane proteins, announces lead monoclonal antibodies (MAbs) against P2X7, a structurally complex ion channel that is the target for autoimmune disorders including atopic dermatitis and glomerulonephritis.

10 Jan 2020

Scaling up use of opioid agonist therapies could help combat Ukraine’s HIV epidemic

A new study led by Yale University researchers finds that scaling up use of methadone and buprenorphine -- medications for treating opioid use disorder known as opioid agonist therapies (OATs) -- could greatly reduce HIV transmission rates and prevent deaths in Ukraine, where the disease is epidemic among people who inject drugs.

3 Jan 2020

Help for teenagers who want to quit smoking

A new study published in the journal JAMA Pediatricsreports on the use of varenicline, a drug that helps smokers quit. The study is unique in that it targeted teenagers who wanted to quit. While confirming the low overall efficacy of the drug, it shows that it may perhaps help teenage smokers to quit faster and to stay smoke-free longer.

11 Dec 2019

Agonist News and Research

Pharmacy-level barriers limit treatment for opioid use disorder in Appalachian Kentucky

New potential treatment candidate identified for early type 2 diabetic retinopathy

Study shows variability in Medicare coverage for transgender hormone therapies

Newer therapies may benefit patients with type 2 diabetes and coronary artery disease

People with type 2 diabetes and heart disease may benefit from newer therapies

Two newer types of diabetes medications show heart and kidney benefits

Study sheds light on myelin's role in 'chemobrain' and multiple sclerosis

Three-drug combination reduces all-cause mortality in COPD patients

Comprehensive new clinical guideline on homelessness released

Collaborative approach needed to build pathways to end homelessness in Canada

Researchers identify mechanism that explains why women experience more pain than men

Nearly $4 million to fund drug discovery research for Alzheimer's, other dementia

Medication treatments for OUD led to 80% lower risk of death from opioid overdose

Researchers find the potential of opioid drug to help mask fear memory

Novel drug combination discovered to induce high rates of human beta cell proliferation

60+ organizations to speak as the NASH Summit Boston returns

Majority of people knowingly use fentanyl, UBC research shows

Integral Molecular announces panel of P2X7 antibodies for autoimmune disorders

Scaling up use of opioid agonist therapies could help combat Ukraine’s HIV epidemic

Help for teenagers who want to quit smoking

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News